Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose-pattern safety evaluation for intraoperative neuromonitoring during lumbar spine surgery
ChiCTR2000039361Phase 4Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in Lumbar Spinal Disease (6 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Somatosensory evoked potential amplitude, Somatosensory evoked potential latency and 2 more. Started Dec 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Lumbar Spinal Disease
Beyond the preview
Go deeper on ChiCTR2000039361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039361.